Judith R. O'Fallon

Irinotecan in the treatment of glioma patients

J. O'fallon, J. Buckner, C. Erlichman, 2003, Cancer.

Prognostic factors in gliomas. A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers

B. Scheithauer, J. Katzmann, V. Ganju, 1994, Cancer.

Prognostic profile for patients with pheochromocytoma derived from clinical and pathological factors and DNA ploidy pattern

J. O'fallon, O. Nativ, S. Sheps, 1992, Journal of surgical oncology.

Cyclophosphamide, adriamycin, and cisdiamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer

J. O'fallon, E. Creagan, J. Woods, 1983, Cancer.

Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors

B. Scheithauer, J. Buckner, J. Krook, 1999, Cancer.

A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy

J. O'fallon, W. Payne, J. Ingle, 1982, American journal of clinical oncology.

Inhibition of 5 ‐ fluorouracil‐induced ocular irritation by ocular ice packs

J. O'fallon, C. Loprinzi, J. Bartel, 1994, Cancer.